Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years
Authors
Keywords
-
Journal
Lancet Haematology
Volume 9, Issue 9, Pages e689-e697
Publisher
Elsevier BV
Online
2022-08-31
DOI
10.1016/s2352-3026(22)00209-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing
- (2021) Maria Elisa Mancuso et al. LANCET
- Intracranial haemorrhage among a population of haemophilic patients in Nepal: Challenges and future direction
- (2021) Bishesh Sharma Poudyal et al. HAEMOPHILIA
- Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes
- (2021) Haowei (Linda) Sun et al. HAEMOPHILIA
- The case for equitable haemophilia care
- (2021) Alok Srivastava Lancet Haematology
- Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender
- (2021) Evemie Dubé et al. HAEMOPHILIA
- Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders
- (2021) Leonard A Valentino et al. Journal of Blood Medicine
- Low‐dose surgical prophylaxis: Optimization of use of World Federation of Hemophilia Humanitarian Aid donated clotting factor concentrates to developing countries
- (2020) Magdy El Ekiaby et al. HAEMOPHILIA
- Show me the evidence: Effectiveness of low‐dose prophylaxis
- (2020) Emna Gouider HAEMOPHILIA
- Invasive procedures in patients with haemophilia: Review of low‐dose protocols and experience with extended half‐life FVIII and FIX concentrates and non‐replacement therapies
- (2020) Cedric Hermans et al. HAEMOPHILIA
- Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms
- (2020) David Lillicrap et al. Expert Review of Hematology
- The World Federation of Hemophilia Annual Global Survey 1999‐2018
- (2020) Jeffrey S. Stonebraker et al. HAEMOPHILIA
- Substitution therapy
- (2020) Midori Shima et al. HAEMOPHILIA
- Hemophilia gene therapy—New country initiatives
- (2020) Ulrike M. Reiss et al. HAEMOPHILIA
- WFH Guidelines for the Management of Hemophilia, 3rd edition
- (2020) Alok Srivastava et al. HAEMOPHILIA
- Feasibility and outcomes of low‐dose and low‐frequency prophylaxis with recombinant extended half‐life products (Fc‐rFVIII and Fc‐rFIX) in Ivorian children with hemophilia: Two‐year experience in the setting of World Federation of Haemophilia humanitarian aid programme
- (2020) Catherine Lambert et al. HAEMOPHILIA
- Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males
- (2019) Alfonso Iorio et al. ANNALS OF INTERNAL MEDICINE
- Achieving the unimaginable: Health equity in haemophilia
- (2019) Mark W. Skinner et al. HAEMOPHILIA
- First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries
- (2018) G. F. Pierce et al. HAEMOPHILIA
- World bleeding disorders registry: The pilot study
- (2018) D. Coffin et al. HAEMOPHILIA
- Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts
- (2016) Emiliana Marrone et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Survey of coagulation factor concentrates tender and procurement procedures in 38 European Countries
- (2015) B. O'Mahony et al. HAEMOPHILIA
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
- (2013) K. Fischer et al. BLOOD
- WFH: Closing the global gap - achieving optimal care
- (2012) MARK W. SKINNER HAEMOPHILIA
- Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®)
- (2011) C. L. BACON et al. HAEMOPHILIA
- Haemophilia in the developing countries: the Iranian experience
- (2010) Peyman Eshghi et al. Archives of Medical Science
- Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities
- (2008) M.-C. POON et al. HAEMOPHILIA
- Haemophilia care then, now and in the future
- (2008) J. OLDENBURG et al. HAEMOPHILIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started